Prevalence of hepatitis B and C virus infection in haematological malignancies and liver injury following chemotherapy-Reference-Cited by-同舟云学术

Prevalence of hepatitis B and C virus infection in haematological malignancies and liver injury following chemotherapy

Published:2005-02 Issue:2 Volume:74 Page:158-165
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Takai Shinji,Tsurumi Hisashi,Ando Kazuki,Kasahara Senji,Sawada Michio,Yamada Toshiki,Hara Takeshi,Fukuno Kenji,Takahashi Takeshi,Oyama Masami,Onishi Hiroo,Tomita Eiichi,Takami Tsuyoshi,Imawari Michio,Moriwaki Hisataka

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0609.2004.00376.x/fullpdf

Reference35 articles.

1. 1. Japan Red Cross . Report of the research group for prophylaxis of post-transfusion hepatitis (editorial) . 1996 ;7 -14 .

2. Hepatitis B infection in patients with lymphomas

3. Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy

4. Severe hepatitis related to chemotherapy in hepatitis B virus carriers with hematologic malignancies: Survey in Japan, 1987-1991

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of hepatitis B virus and hepatitis C virus infections in patients with Hodgkin's and non-Hodgkin’s lymphoma;International Journal of Immunopathology and Pharmacology;2023-10-19

2. Hepatitis Virus-associated Non-hodgkin Lymphoma: Pathogenesis and Treatment Strategies;Journal of Clinical and Translational Hepatology;2023-05-30

3. KASL clinical practice guidelines for management of chronic hepatitis B;Clinical and Molecular Hepatology;2022-04-01

4. lncNBAT1/APOBEC3A is a mediator of HBX-induced chemoresistance in diffuse large B cell lymphoma cells;Molecular Therapy - Nucleic Acids;2022-03

5. Management of hepatitis B and C in special population;World Journal of Gastroenterology;2021-10-28